In coherence with cytoplasmic HIF-2α staining at low intensity in PCCs overall, there was no difference in expression in non-metastatic as compared to metastatic tumors (Fig. 2G; Supplementary Table S5). This evidence concerns the gene EPAS1 and metastatic neoplasm.